Clinical Trials Browser

Phase 2 × Solid Cancers × pertuzumab × Clear all

NCT00096941 2015-06-11

A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study

Phase 2 Completed

3 enrolled 5 charts

Solid Cancers